Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Clin Exp Rheumatol Retrieve available abstracts of 193 articles: HTML format

Single Articles

March 2023
1. MOHAMED AHAMADA M, Wu X
   Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis.
   Clin Exp Rheumatol. 2023 Mar 7. doi: 10.55563.
   PubMed     Abstract available
   
   
   
2. CACCIAPAGLIA F, Spinelli FR, Erre GL, Gremese E, et al
   Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology.
   Clin Exp Rheumatol. 2023 Mar 2. doi: 10.55563.
   PubMed     Abstract available
   
   
   
3. GERTEL S, Polachek A, Furer V, Paran D, et al
   Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo study.
   Clin Exp Rheumatol. 2023 Mar 2. doi: 10.55563.
   PubMed     Abstract available
   
   
   February 2023
4. YAMAZAKI K, Kiyomi A, Imai S, Sugiyama K, et al
   Effect of prednisolone and saireito co-administration on T-cells of rheumatoid arthritis patients.
   Clin Exp Rheumatol. 2023 Feb 24. doi: 10.55563.
   PubMed     Abstract available
   
   
   
5. PENG W, Wu S, Wang W
   Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis.
   Clin Exp Rheumatol. 2023 Feb 23. doi: 10.55563.
   PubMed     Abstract available
   
   
   January 2023
6. ALMEIDA-SANTIAGO C, Quevedo-Abeledo JC, Hernandez-Hernandez V, de Vera-Gonzalez A, et al
   Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy.
   Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
   PubMed     Abstract available
   
   
   
7. KOHNO H, Sugimoto T, Yoshida Y, Mokuda S, et al
   Association between increased serum IL-23 levels and ACPA positivity in patients with rheumatoid arthritis.
   Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
   PubMed    
   
   
   
8. ANYFANTI P, Gavriilaki E, Dolgyras P, Nikolaidou B, et al
   Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities.
   Clin Exp Rheumatol. 2023 Jan 26. doi: 10.55563.
   PubMed     Abstract available
   
   
   
9. SANNA GD, Piga M, Piga A, Falco O, et al
   Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study.
   Clin Exp Rheumatol. 2023 Jan 2. doi: 10.55563.
   PubMed     Abstract available
   
   
   
10. OUATAH H, Authier N, Tournadre A, Fan A, et al
    Frequency of cannabis use in patients with rheumatoid arthritis or spondyloarthropathies: a single-centre study.
    Clin Exp Rheumatol. 2023;41:198.
    PubMed    
    
    
    December 2022
11. SAITO S, Suzuki K, Yoshimoto K, Kondo Y, et al
    Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Dec 15. doi: 10.55563.
    PubMed     Abstract available
    
    
    
12. HILLIQUIN S, Herrou J, Guterman L, Goulvestre C, et al
    Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study.
    Clin Exp Rheumatol. 2022 Dec 7. doi: 10.55563.
    PubMed     Abstract available
    
    
    
13. YANG W, Xu Y, Lin J, Liu J, et al
    Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study.
    Clin Exp Rheumatol. 2022 Dec 5. doi: 10.55563.
    PubMed     Abstract available
    
    
    
14. CARLOTTI E, Murray-Brown W, Blighe K, Caliste M, et al
    High-throughput sequencing of IgH gene in minor salivary glands from Sjogren's syndrome patients reveals dynamic B cell recirculation between ectopic lymphoid structures.
    Clin Exp Rheumatol. 2022;40:2363-2372.
    PubMed     Abstract available
    
    
    
15. FULVIO G, Donati V, Izzetti R, Fonzetti S, et al
    Correspondence between minor salivary glands ultra-high frequency ultrasonography and histology: a case report of severe/atypical lymphoid infiltrate in Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2474-2475.
    PubMed    
    
    
    
16. STERGIOU IE, Chatzis LG, Pezoulas VC, Baldini C, et al
    The clinical phenotype of primary Sjogren's syndrome patients with lymphadenopathy.
    Clin Exp Rheumatol. 2022;40:2357-2362.
    PubMed     Abstract available
    
    
    
17. MANFRE V, Chatzis LG, Cafaro G, Fonzetti S, et al
    Sjogren's syndrome: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:2211-2224.
    PubMed     Abstract available
    
    
    
18. PRIORI R, Giardina F, Gioia C, Iannuccelli C, et al
    Cultural adaptation and preliminary validation of the Qualisex questionnaire for its use in patients with Sjogren's syndrome and fibromyalgia in Italy.
    Clin Exp Rheumatol. 2022;40:2470-2471.
    PubMed    
    
    
    
19. FLORES-CHAVEZ A, Ng WF, Alunno A, Inanc N, et al
    Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients.
    Clin Exp Rheumatol. 2022;40:2329-2337.
    PubMed     Abstract available
    
    
    
20. LA ROCCA G, Ferro F, Bulleri A, Fulvio G, et al
    Glandular involvement in primary Sjogren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    Clin Exp Rheumatol. 2022;40:2344-2349.
    PubMed     Abstract available
    
    
    
21. DE WOLFF L, Vissink A, van Nimwegen JF, van Zuiden G, et al
    Patient Acceptable Symptom State (PASS) in patients with primary Sjogren's syndrome in daily clinical practice.
    Clin Exp Rheumatol. 2022;40:2303-2309.
    PubMed     Abstract available
    
    
    
22. INANC N, Kostov B, Priori R, Flores-Chavez A, et al
    Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjogren syndrome.
    Clin Exp Rheumatol. 2022;40:2290-2297.
    PubMed     Abstract available
    
    
    
23. ZABOTTI A, Pegolo E, Giovannini I, Manfre V, et al
    Usefulness of ultrasound guided core needle biopsy of the parotid gland for the diagnosis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2381-2386.
    PubMed     Abstract available
    
    
    
24. LUO J, Zhang Y, Chen JQ, Song WJ, et al
    Distinct clinical phenotypes of primary Sjogren's syndrome differ by onset age: a retrospective study of 742 cases and review of the literature.
    Clin Exp Rheumatol. 2022;40:2373-2380.
    PubMed     Abstract available
    
    
    
25. SILVERIO-ANTONIO M, Alves Ribeiro L, Medeiros J, Fonseca JE, et al
    Sjogren's syndrome presenting as thrombotic thrombocytopenic purpura in a male patient with previous Kikuchi-Fujimoto disease.
    Clin Exp Rheumatol. 2022;40:2472-2473.
    PubMed    
    
    
    
26. BELLOS S, Velonakis G, Anagnostouli M, Mavragani CP, et al
    Posterior reversible encephalopathy syndrome in a patient with anticentromere positive Sjogren's syndrome/mixed connective tissue disease overlap: a case report and review of the literature.
    Clin Exp Rheumatol. 2022;40:2468-2469.
    PubMed    
    
    
    
27. YANG T, Delli K, Coumou AD, van der Vegt B, et al
    The lacrimal gland in Sjogren's syndrome: can we unravel its mystery using ultrasound?
    Clin Exp Rheumatol. 2022;40:2428-2433.
    PubMed     Abstract available
    
    
    
28. KAKLAMANOS A, Goules AV, Tzioufas AG
    Experimental models of Sjogren's syndrome: differences and similarities with human disease.
    Clin Exp Rheumatol. 2022;40:2398-2412.
    PubMed     Abstract available
    
    
    
29. ARENDS S, de Wolff L, Deroo L, Verstappen GM, et al
    Selection of study endpoints and patients for clinical trials in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2225-2232.
    PubMed     Abstract available
    
    
    
30. DELLI K, van Ginkel MS, Vissink A, Stel AJ, et al
    Can salivary gland ultrasonography replace salivary gland biopsy in the diagnosis of Sjogren's syndrome?
    Clin Exp Rheumatol. 2022;40:2443-2449.
    PubMed     Abstract available
    
    
    
31. WANG X, Wang A, Zhan X, Xu L, et al
    Value of conventional ultrasound and shear wave elastography in assessing disease activity and prognosis in female patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2350-2356.
    PubMed     Abstract available
    
    
    
32. PRAK RF, Arends S, Verstappen GM, van Zuiden G, et al
    Fatigue in primary Sjogren's syndrome is associated with an objective decline in physical performance, pain and depression.
    Clin Exp Rheumatol. 2022;40:2318-2328.
    PubMed     Abstract available
    
    
    
33. CORDEIRO RA, de Oliveira JL, Ferraciolli SF, Guedes LKN, et al
    Neurosarcoidosis during the treatment of primary Sjogren's syndrome: is it a paradoxical effect of rituximab?
    Clin Exp Rheumatol. 2022;40:2464-2465.
    PubMed    
    
    
    
34. DE VITA S, Zabotti A, Tommasini A, Dorner T, et al
    The importance of studying the parotid glands in primary Sjogren's syndrome: the right tissue at the right time.
    Clin Exp Rheumatol. 2022;40:2233-2236.
    PubMed    
    
    
    
35. CERESER L, Giovannini I, Caronia G, Zabotti A, et al
    Chest high-resolution computed tomography in primary Sjogren's syndrome: an up-to-date primer for rheumatologists.
    Clin Exp Rheumatol. 2022;40:2450-2462.
    PubMed     Abstract available
    
    
    
36. WITTE T, Engelke F, Ritter J, Dorner T, et al
    Towards the identification of novel autoantibodies in Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2395-2397.
    PubMed     Abstract available
    
    
    
37. GOULES AV, Pringle S, Ramos-Casals M, Tzioufas AG, et al
    Pathophysiology of Sjogren's-like syndrome induced by cancer immunotherapies: similarities and differences with classical Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2237-2239.
    PubMed    
    
    
    
38. PRINGLE S, Verstappen GM, van Ginkel MS, Nakshbandi U, et al
    Lymphoepithelial lesions in the salivary glands of primary Sjogren's syndrome patients: the perfect storm?
    Clin Exp Rheumatol. 2022;40:2434-2442.
    PubMed     Abstract available
    
    
    
39. BRITO-ZERON P, Retamozo S, Flores-Chavez A, Akasbi M, et al
    Practical diagnostic tips for the Sjogren Clinic: pearls, myths and mistakes.
    Clin Exp Rheumatol. 2022;40:2413-2427.
    PubMed     Abstract available
    
    
    
40. CAFARO G, Perricone C, Bursi R, Riccucci I, et al
    Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjogren's syndrome: an inter-system reproducibility study.
    Clin Exp Rheumatol. 2022;40:2253-2257.
    PubMed     Abstract available
    
    
    
41. DEROO L, Achten H, De Boeck K, Genbrugge E, et al
    The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2310-1317.
    PubMed     Abstract available
    
    
    
42. CHATZIS LG, Koulouri V, Baldini C, Pezoulas VC, et al
    Clinical and laboratory findings of primary Sjogren's syndrome patients without sicca symptoms.
    Clin Exp Rheumatol. 2022;40:2298-2302.
    PubMed     Abstract available
    
    
    
43. AMEZCUA-GUERRA LM, Sanchez-Munoz F, Pichardo-Ontiveros E, Gonzalez-Ramirez J, et al
    Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as well as chemokine production, in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2275-2282.
    PubMed     Abstract available
    
    
    
44. MARTINS VAO, Floriano TF, Leon EP, Villamarin LEB, et al
    Primary dental care treatment in primary Sjogren's syndrome: a possible role in improving salivary flow rate.
    Clin Exp Rheumatol. 2022;40:2258-2267.
    PubMed     Abstract available
    
    
    
45. XU R, Yan Q, Gong Y, Cai CS, et al
    Tacrolimus therapy in primary Sjogren's syndrome with refractory immune thrombocytopenia: a retrospective study.
    Clin Exp Rheumatol. 2022;40:2268-2274.
    PubMed     Abstract available
    
    
    
46. KIM SH, Min HK, Lee SH, Lee KA, et al
    Ultrasonographic evaluation of lacrimal glands in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2283-2289.
    PubMed     Abstract available
    
    
    
47. STEINMETZ TD, de Wolff L, Terpstra JH, Visser A, et al
    Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2022;40:2338-2343.
    PubMed     Abstract available
    
    
    
48. TAKAGI Y, Hashimoto K, Sasaki M, Eida S, et al
    Juvenile onset of primary Sjogren's syndrome: changes in imaging findings during a 7-year progression.
    Clin Exp Rheumatol. 2022;40:2466-2467.
    PubMed    
    
    
    
49. HE J, Jiang J, Baumgart K
    Candidate autoantibodies for primary Sjogren's syndrome: where are they now?
    Clin Exp Rheumatol. 2022;40:2387-2394.
    PubMed     Abstract available
    
    
    
50. LUO J, Song WJ, Chen JQ, Yang GY, et al
    Factors associated with secondary immune thrombocytopenia in patients with primary Sjogren's syndrome: a retrospective study of 639 cases.
    Clin Exp Rheumatol. 2022;40:2245-2252.
    PubMed     Abstract available
    
    
    
51. CRUZ-BAUTISTA I, Almeda-Valdes P, Lopez-Carrasco G, Astudillo M, et al
    Total body water and sicca symptoms in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2022;40:2240-2244.
    PubMed     Abstract available
    
    
    November 2022
52. GERMONPRE S, Mulier S, Falzon L, Boonen A, et al
    Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available
    
    
    
53. DE SOUZA FFL, Schneider AH, Machado CC, de Almeida SCL, et al
    Synovial fluid survivin and NETs as independent biomarkers in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available
    
    
    
54. WAJDA A, Stypinska B, Czarnecka M, Hasan D, et al
    Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18825.
    PubMed     Abstract available
    
    
    
55. NOVELLA-NAVARRO M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, et al
    A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification.
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18765.
    PubMed     Abstract available
    
    
    
56. VITTECOQ O, Kozyreff-Meurice M, Houivet E, Leon N, et al
    Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study.
    Clin Exp Rheumatol. 2022 Nov 12. pii: 18669.
    PubMed     Abstract available
    
    
    
57. BEN-CHETRIT E, Ben-Chetrit E
    Reply to comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2022;40:2201.
    PubMed    
    
    
    
58. ANDREICA I, Jast R, Rezniczek GA, Kiefer D, et al
    Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
    Clin Exp Rheumatol. 2022;40:2044-2051.
    PubMed     Abstract available
    
    
    October 2022
59. ZHANG X, Wang H, Song X, Song Y, et al
    Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 29. pii: 18748.
    PubMed     Abstract available
    
    
    
60. TANAKA Y, Takahashi T, Van Hoogstraten H, Praestgaard A, et al
    Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
    Clin Exp Rheumatol. 2022 Oct 28. pii: 18235.
    PubMed     Abstract available
    
    
    
61. CHANG CK, Chang KH, Cheng WC, Chen PK, et al
    Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18824.
    PubMed     Abstract available
    
    
    
62. JEONG E, Jung JY, Lee MJ, Kim HA, et al
    A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18772.
    PubMed     Abstract available
    
    
    September 2022
63. DING JT, Hong FF, Yang SL
    Roles of autophagy in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Sep 22. pii: 18442.
    PubMed     Abstract available
    
    
    
64. YAVROPOULOU MP, Filippa MG, Panopoulos S, Spanos E, et al
    Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
    Clin Exp Rheumatol. 2022;40:1789-1792.
    PubMed     Abstract available
    
    
    
65. YANG H, Luo Y, Lai X
    Il-34 regulates MAPKs, PI3K/Akt, JAK and NF-kappaB pathways and induces the expression of inflammatory factors in RA-FLS.
    Clin Exp Rheumatol. 2022;40:1779-1788.
    PubMed     Abstract available
    
    
    
66. WESTON S, Macdonald JL, Williams LM, Roussou E, et al
    The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Clin Exp Rheumatol. 2022;40:1620-1628.
    PubMed     Abstract available
    
    
    August 2022
67. LEE JY, Kim SH, Lee SH, Kim HR, et al
    Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Aug 31. pii: 18678.
    PubMed     Abstract available
    
    
    
68. JUNG JY, Lee E, Kim JW, Suh CH, et al
    Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry.
    Clin Exp Rheumatol. 2022 Aug 31. pii: 18570.
    PubMed     Abstract available
    
    
    
69. DUARTE C, Santos E, Barreira SC, Avila-Ribeiro P, et al
    Can numerical rating scales of disease impact be used as targets for patient-centred management in rheumatoid arthritis?
    Clin Exp Rheumatol. 2022 Aug 5. pii: 18562.
    PubMed     Abstract available
    
    
    
70. KOUKI I, Sacco I, Eymard F, Fautrel B, et al
    An adult-onset Still's disease during infection with Chlamydia trachomatis.
    Clin Exp Rheumatol. 2022 Aug 1. pii: 18800.
    PubMed    
    
    
    July 2022
71. DROSOS AA, Pelechas E, Venetsanopoulou AI, Voulgari PV, et al
    Comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2022 Jul 26. pii: 18811.
    PubMed    
    
    
    
72. GUELLEC D, Carvajal-Alegria G, Daien C, Gossec L, et al
    Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort.
    Clin Exp Rheumatol. 2022 Jul 21. pii: 18514.
    PubMed     Abstract available
    
    
    
73. GARAFFONI C, Adinolfi A, Bortoluzzi A, Filippou G, et al
    Novel insights into the management of rheumatoid arthritis: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:1247-1257.
    PubMed     Abstract available
    
    
    
74. PELLEGRINO G, Mancuso S, Colasanti T, Mieli S, et al
    Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
    Clin Exp Rheumatol. 2022;40:1417-1419.
    PubMed     Abstract available
    
    
    
75. GALLOWAY J, Raine T, Rivett L, Roberts J, et al
    Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination.
    Clin Exp Rheumatol. 2022;40:1432-1441.
    PubMed     Abstract available
    
    
    
76. RAVAEI A, Rubini M
    Rescuing effect of folates on methotrexate cytotoxicity in human trophoblast cells.
    Clin Exp Rheumatol. 2022;40:1403-1410.
    PubMed     Abstract available
    
    
    June 2022
77. SAKELLARIOU G, Carrara G, Zanetti A, Scire CA, et al
    Do we need Early Arthritis Clinics to counteract the excess of mortality in rheumatoid arthritis?
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18227.
    PubMed    
    
    
    
78. WEMAN L, Vehmas J, Immonen J, Hannonen P, et al
    Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18494.
    PubMed     Abstract available
    
    
    
79. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
    Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose.
    Clin Exp Rheumatol. 2022 Jun 13. pii: 18477.
    PubMed     Abstract available
    
    
    
80. GUL HL, Di Matteo A, Mankia K, Wu J, et al
    Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?
    Clin Exp Rheumatol. 2022 Jun 13. pii: 18334.
    PubMed     Abstract available
    
    
    May 2022
81. LEE H, Chen SK, Gautam N, Vine SM, et al
    Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
    Clin Exp Rheumatol. 2022 May 10. pii: 18274.
    PubMed     Abstract available
    
    
    
82. DI COLA I, Di Muzio C, Conforti A, Iacono D, et al
    Adult-onset Still's disease with elderly onset, results from a multicentre study.
    Clin Exp Rheumatol. 2022 May 4. pii: 18230.
    PubMed     Abstract available
    
    
    
83. CECCARELLI F, Spinelli FR, Garufi C, Mancuso S, et al
    The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort.
    Clin Exp Rheumatol. 2022;40:921-927.
    PubMed     Abstract available
    
    
    
84. GAUD-LISTRAT V, Lopez-Medina C, Hudry C, Nguyen M, et al
    Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
    Clin Exp Rheumatol. 2022;40:928-935.
    PubMed     Abstract available
    
    
    
85. BALDINI C, Arnaud L, Avcin T, Beretta L, et al
    Sjogren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
    Clin Exp Rheumatol. 2022;40 Suppl 134:103-112.
    PubMed     Abstract available
    
    
    
86. MUCKE J, Cornet A, Witte T, Schneider M, et al
    Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:40-45.
    PubMed     Abstract available
    
    
    
87. PETITDEMANGE A, Sztejkowski C, Damian L, Martin T, et al
    Treatment of relapsing polychondritis: a systematic review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:81-85.
    PubMed     Abstract available
    
    
    April 2022
88. LARSSON C, Andersson KME, Nadali M, Silfversward ST, et al
    MicroRNA and interleukin 6 interplay in the adipose tissue of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Apr 29. pii: 18013.
    PubMed     Abstract available
    
    
    
89. MARTIN-GONZALEZ C, Martin-Folgueras T, Quevedo-Abeledo JC, de Armas-Rillo L, et al
    Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.
    Clin Exp Rheumatol. 2022 Apr 6. pii: 18203.
    PubMed     Abstract available
    
    
    March 2022
90. KEYSTONE E, Movahedi M, Cesta A, Bombardier C, et al
    Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative.
    Clin Exp Rheumatol. 2022 Mar 30. pii: 17725.
    PubMed     Abstract available
    
    
    
91. LIN T, Xu S, Wang Y, Nian X, et al
    Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
    Clin Exp Rheumatol. 2022 Mar 23. pii: 18186.
    PubMed     Abstract available
    
    
    
92. CAMPOCHIARO C, Farina N, Tomelleri A, De Luca G, et al
    Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
    Clin Exp Rheumatol. 2022 Mar 18. pii: 17994.
    PubMed    
    
    
    
93. KLEMM P, Hoffmann J, Asendorf T, Aykara I, et al
    Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trial.
    Clin Exp Rheumatol. 2022 Mar 1. pii: 17706.
    PubMed     Abstract available
    
    
    
94. PETRELLI F, Mariani FM, Alunno A, Puxeddu I, et al
    Pathogenesis of rheumatoid arthritis: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:475-482.
    PubMed     Abstract available
    
    
    
95. HUANG T, Li Y, Luo Y, Zhou Y, et al
    Research progress on the pathogenesis and quality of life of patients with primary Sjogren's syndrome complicated by depression.
    Clin Exp Rheumatol. 2022;40:647-654.
    PubMed     Abstract available
    
    
    February 2022
96. VERHOEVEN MMA, Westgeest AAA, Tekstra J, van Laar JM, et al
    Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17657.
    PubMed     Abstract available
    
    
    
97. KANG JH, Choi SE, Xu H, Park DJ, et al
    Non-adherence to methotrexate was associated with high disease activity and poor health-related outcomes during a 4-year follow-up of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17574.
    PubMed     Abstract available
    
    
    
98. NODA K, Saitou M, Matsushita T, Ukichi T, et al
    How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17676.
    PubMed     Abstract available
    
    
    
99. WU B, Peng R, Chen Y, Zhong J, et al
    Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17730.
    PubMed     Abstract available
    
    
    
100. MURRAY MT, Penney SP, Landman A, Elias J, et al
     User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Feb 1. pii: 16841.
     PubMed     Abstract available
     
     
     January 2022
101. HIROHATA S, Nagai T, Tomita T
     Enhanced expression of mRNA for transforming growth factor beta activated kinase 1 in CD34+ cells of the bone marrow in rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Jan 27. pii: 17941.
     PubMed     Abstract available
     
     
     
102. MASNERI S, Piantoni S, Galoppini G, Regola F, et al
     CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept.
     Clin Exp Rheumatol. 2022 Jan 27. pii: 17712.
     PubMed     Abstract available
     
     
     
103. KALYONCU U, Bilgin E, Erden A, Satis H, et al
     Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17973.
     PubMed     Abstract available
     
     
     
104. TAKASHIMA Y, Hayashi S, Maeda T, Fukuda K, et al
     Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-alpha inhibitors or IL-6 inhibitors.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17785.
     PubMed     Abstract available
     
     
     
105. SMITH ID, Lu N, Wei J, Zhang Y, et al
     Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2022 Jan 25. pii: 17761.
     PubMed     Abstract available
     
     
     
106. FORNARO M, Benaglio F, Montecucco C, Raffeiner B, et al
     Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of t
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17698.
     PubMed     Abstract available
     
     
     
107. NOVELLA-NAVARRO M, Genre F, Hernandez-Breijo B, Remuzgo-Martinez S, et al
     Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17782.
     PubMed     Abstract available
     
     
     
108. MYACHIKOVA V, Moiseeva O, Konradi A, Lapin SV, et al
     A retrospective analysis of colchicine in combination with NSAIDs therapy in patients with systemic form of adult-onset Still's disease with serositis.
     Clin Exp Rheumatol. 2022 Jan 12. pii: 17765.
     PubMed     Abstract available
     
     
     
109. ISSA SF, Lindegaard HM, Lorenzen T, Junker K, et al
     Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
     Clin Exp Rheumatol. 2022;40:198.
     PubMed    
     
     
     December 2021
110. PODGORSKA D, Ciesla M, Majdan M, Podgorski R, et al
     The relationship of ADAMTSL2 and LRPAP1 gene methylation level with rheumatoid arthritis activity.
     Clin Exp Rheumatol. 2021 Dec 22. pii: 17757.
     PubMed     Abstract available
     
     
     November 2021
111. MODARRESI CHAHARDEHI A, Masoumi SA, Bigdeloo M, Arsad H, et al
     The effect of exercise on patients with rheumatoid arthritis on the modulation of inflammation.
     Clin Exp Rheumatol. 2021 Nov 23. pii: 17457.
     PubMed     Abstract available
     
     
     
112. SPECKER C, Aringer M, Burmester GR, Killy B, et al
     The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
     Clin Exp Rheumatol. 2021 Nov 22. pii: 17272.
     PubMed     Abstract available
     
     
     
113. LAYEGH Z, Hooijberg F, Bastida C, Huitema ADR, et al
     Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17173.
     PubMed    
     
     
     
114. SUGAWARA M, Fujieda Y, Noguchi A, Tanimura S, et al
     Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis.
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17548.
     PubMed     Abstract available
     
     
     
115. ALDRIDGE J, Lundell AC, Andersson K, Mark L, et al
     Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Nov 3. pii: 17505.
     PubMed     Abstract available
     
     
     
116. BEN-CHETRIT E, Ben-Chetrit E
     Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
     Clin Exp Rheumatol. 2021;39:1410-1412.
     PubMed     Abstract available
     
     
     
117. CHOWDHURY F, Grigoriadou S, Bombardieri M
     Severity of COVID-19 infection in primary Sjogren's syndrome and the emerging evidence of COVID-19-induced xerostomia.
     Clin Exp Rheumatol. 2021;39 Suppl 133:215-222.
     PubMed     Abstract available
     
     
     
118. RETAMOZO S, Acar-Denizli N, Horvath IF, Ng WF, et al
     Influence of the age at diagnosis in the disease expression of primary Sjogren syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium.
     Clin Exp Rheumatol. 2021;39 Suppl 133:166-174.
     PubMed     Abstract available
     
     
     
119. DUBOST JJ, Couderc M, Pereira B, Mariette X, et al
     Concomitant fibromyalgia in primary Sjogren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
     Clin Exp Rheumatol. 2021;39 Suppl 133:140-145.
     PubMed     Abstract available
     
     
     
120. LOUREIRO-AMIGO J, Franco-Jarava C, Perurena-Prieto J, Palacio C, et al
     Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:131-139.
     PubMed     Abstract available
     
     
     
121. CAFARO G, Bursi R, Chatzis LG, Fulvio G, et al
     One year in review 2021: Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:3-13.
     PubMed     Abstract available
     
     
     
122. SISO-ALMIRALL A, Meijer JM, Brito-Zeron P, Conangla L, et al
     Practical guidelines for the early diagnosis of Sjogren's syndrome in primary healthcare.
     Clin Exp Rheumatol. 2021;39 Suppl 133:197-205.
     PubMed     Abstract available
     
     
     
123. CARUBBI F, Alunno A, Mai F, Mercuri A, et al
     Adherence to the Mediterranean diet and the impact on clinical features in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:190-196.
     PubMed     Abstract available
     
     
     
124. SEGHIERI C, Lupi E, Tzioufas AG, De Vita S, et al
     Patient-reported experience and health-related quality of life in patients with primary Sjogren's syndrome in Europe.
     Clin Exp Rheumatol. 2021;39 Suppl 133:123-130.
     PubMed     Abstract available
     
     
     
125. BRITO-ZERON P, Acar-Denizli N, Romao VC, Armagan B, et al
     Post-COVID-19 syndrome in patients with primary Sjogren's syndrome after acute SARS-CoV-2 infection.
     Clin Exp Rheumatol. 2021;39 Suppl 133:57-65.
     PubMed     Abstract available
     
     
     
126. KOH JH, Park Y, Lee J, Park SH, et al
     Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjogren's syndrome: results from the KISS cohort study.
     Clin Exp Rheumatol. 2021;39 Suppl 133:114-122.
     PubMed     Abstract available
     
     
     
127. LEGGER GE, Erdtsieck MB, de Wolff L, Stel AJ, et al
     Differences in presentation between paediatric- and adult-onset primary Sjogren's syndrome patients.
     Clin Exp Rheumatol. 2021;39 Suppl 133:85-92.
     PubMed     Abstract available
     
     
     
128. ZHANG X, Zhang S, Feng R, Yao H, et al
     Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:184-189.
     PubMed     Abstract available
     
     
     
129. DE WOLFF L, Arends S, Pontarini E, Bombardieri M, et al
     Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:100-106.
     PubMed     Abstract available
     
     
     
130. BEJARANO MV, Romanini F, Catalan Pellet A, Mamani MN, et al
     Work productivity and activity impairment in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:93-99.
     PubMed     Abstract available
     
     
     
131. CHATZIS LG, Goules AV, Tzioufas AG
     Searching for the "X factor" in Sjogren's syndrome female predilection.
     Clin Exp Rheumatol. 2021;39 Suppl 133:206-214.
     PubMed     Abstract available
     
     
     
132. LORENZON M, Tulipano Di Franco F, Zabotti A, Pegolo E, et al
     Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:175-183.
     PubMed     Abstract available
     
     
     
133. FARENHORST CA, de Wolff L, Arends S, van Nimwegen JF, et al
     Clinical determinants of vaginal dryness in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:73-79.
     PubMed     Abstract available
     
     
     
134. PRINGLE SA, Berkhof B, van Ginkel M, Liefers S, et al
     Parotid salivary sodium levels of Sjogren's syndrome patients suggest B-cell mediated epithelial sodium channel disruption.
     Clin Exp Rheumatol. 2021;39 Suppl 133:30-38.
     PubMed     Abstract available
     
     
     
135. CHATZIS LG, Pezoulas V, Voulgari PV, Baldini C, et al
     Combined seronegativity in Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:80-84.
     PubMed     Abstract available
     
     
     
136. GOZUKUCUK M, Turkyilmaz E, Kucuksahin O, Erten S, et al
     Effects of primary Sjogren's syndrome on female genitalia and sexual functions.
     Clin Exp Rheumatol. 2021;39 Suppl 133:66-72.
     PubMed     Abstract available
     
     
     
137. PENG X, Lu Y, Wei J, Lin T, et al
     A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjogren's syndrome patients with dry eye disease.
     Clin Exp Rheumatol. 2021;39 Suppl 133:159-165.
     PubMed     Abstract available
     
     
     
138. COLEBY R, Lucchesi D, Pontarini E, Pitzalis C, et al
     Stepwise changes in the murine salivary gland immune response during virally-induced ectopic lymphoid structure formation.
     Clin Exp Rheumatol. 2021;39 Suppl 133:39-48.
     PubMed     Abstract available
     
     
     
139. HERNANDEZ-MOLINA G, Soto-Abraham V, Zamora-Legoff V, Furuzawa-Carballeda J, et al
     Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjogren's syndrome and systemic lupus erythematosus associated with Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:49-56.
     PubMed     Abstract available
     
     
     
140. RAMOS-CASALS M, Sainz-de-la-Maza M, Muxi A
     COVID-19 vaccination unveiling subclinical Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:228-229.
     PubMed    
     
     
     
141. XU T, Guo Y, Lu J, Shan J, et al
     Untargeted serum metabolomics and potential biomarkers for Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:23-29.
     PubMed     Abstract available
     
     
     
142. SANDOVAL-FLORES MG, Chan-Campos I, Hernandez-Molina G
     Factors influencing the EULAR Sjogren's Syndrome Patient-Reported Index in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39 Suppl 133:153-158.
     PubMed     Abstract available
     
     
     
143. KOMORI K, Komori M, Horino T, Nishiyama S, et al
     Factors associated with delayed diagnosis of Sjogren's syndrome among members of the Japanese Sjogren's Association for Patients.
     Clin Exp Rheumatol. 2021;39 Suppl 133:146-152.
     PubMed     Abstract available
     
     
     
144. GUNDOGUS B, Yildiz T, Agca M, Erdagi A, et al
     Sjogren's syndrome and pulmonary alveolar proteinosis co-existence.
     Clin Exp Rheumatol. 2021;39 Suppl 133:230.
     PubMed    
     
     
     
145. LANG J, Shi X, Ma Y, Zou L, et al
     Primary Sjogren's syndrome with minimal change disease: case series and literature review.
     Clin Exp Rheumatol. 2021;39 Suppl 133:226-227.
     PubMed    
     
     
     
146. JAGER-WITTENAAR H, Vissink A, Kroese FGM, Bootsma H, et al
     Undernutrition and sarcopenic obesity: underrecognised conditions in patients with Sjogren's syndrome?
     Clin Exp Rheumatol. 2021;39 Suppl 133:20-22.
     PubMed    
     
     
     
147. VIEIRA A, Grosjean A, Stone L, Oosterbaan M, et al
     Sjogren's: the European patients' community perspective.
     Clin Exp Rheumatol. 2021;39 Suppl 133:14-16.
     PubMed    
     
     
     
148. GENET L, Jalladaud M, Seror R, Gosset M, et al
     Plasma cell gingivitis, an underestimated condition in patients with Sjogren's syndrome?
     Clin Exp Rheumatol. 2021;39 Suppl 133:225.
     PubMed    
     
     
     
149. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
     Type II cryoglobulinaemic vasculitis with primary Sjogren's syndrome successfully treated with belimumab and hydroxychloroquine.
     Clin Exp Rheumatol. 2021;39 Suppl 133:223-224.
     PubMed    
     
     
     October 2021
150. CAFARO G, Perricone C, Riccucci I, Bursi R, et al
     Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjogren's syndrome and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Oct 18. pii: 17870.
     PubMed     Abstract available
     
     
     September 2021
151. KLEMM P, Preusler P, Hudowenz O, Asendorf T, et al
     Effects of multimodal rheumatologic complex treatment in patients with rheumatoid arthritis: a monocentric prospective study.
     Clin Exp Rheumatol. 2021 Sep 28. pii: 17318.
     PubMed     Abstract available
     
     
     
152. THOMPSON AE, Pope JE
     The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Sep 21. pii: 17449.
     PubMed     Abstract available
     
     
     
153. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
     Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort.
     Clin Exp Rheumatol. 2021 Sep 21. pii: 17302.
     PubMed     Abstract available
     
     
     
154. ZHENG B, Soares de Moura C, Machado M, Pineau CA, et al
     Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 17256.
     PubMed     Abstract available
     
     
     
155. PERNIOLA S, Bizzoca R, Fornaro M, Alivernini S, et al
     High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 16999.
     PubMed     Abstract available
     
     
     
156. DURAN E, Yildirim BES, Karadag O
     Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
     Clin Exp Rheumatol. 2021 Sep 7. pii: 17387.
     PubMed    
     
     
     
157. MARIOTTE A, Bernardi L, Macquin C, DeCauwer A, et al
     NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models.
     Clin Exp Rheumatol. 2021;39:982-987.
     PubMed     Abstract available
     
     
     
158. YAO H, Wang Y, Wang Z, Zhao J, et al
     The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
     Clin Exp Rheumatol. 2021;39 Suppl 132:129-134.
     PubMed     Abstract available
     
     
     
159. YANG CA, Chen PK, Lan JL, Chang CK, et al
     Expression signature of inflammation-associated long non-coding RNAs in adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:67-74.
     PubMed     Abstract available
     
     
     
160. GAO Q, Yuan Y, Wang Y, Jiang J, et al
     Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:59-66.
     PubMed     Abstract available
     
     
     
161. AIZAKI Y, Yazawa H, Sato K, Mimura T, et al
     Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
     Clin Exp Rheumatol. 2021;39 Suppl 132:22-29.
     PubMed     Abstract available
     
     
     
162. YAMAMOTO S, Nishimura K, Yo K, Waki D, et al
     Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine.
     Clin Exp Rheumatol. 2021;39 Suppl 132:139-140.
     PubMed    
     
     
     August 2021
163. KITAMURA N, Sugiyama K, Nagasawa Y, Hamaguchi M, et al
     Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Aug 5. pii: 17140.
     PubMed     Abstract available
     
     
     July 2021
164. CIESLA M, Kolarz B, Majdan M, Darmochwal-Kolarz D, et al
     Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 24. pii: 16995.
     PubMed     Abstract available
     
     
     
165. LEE K, Min HK, Koh SH, Lee SH, et al
     Prognostic signature of interferon-gamma and interleurkin-17A in early rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 23. pii: 17190.
     PubMed     Abstract available
     
     
     
166. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
     The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
     PubMed     Abstract available
     
     
     
167. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
     Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
     Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
     PubMed     Abstract available
     
     
     
168. MATSUNO H, Kang YM, Okada M, Lee SI, et al
     Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
     Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
     PubMed     Abstract available
     
     
     
169. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
     One year in review 2021: novelties in the treatment of rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39:705-720.
     PubMed     Abstract available
     
     
     
170. MONA M, Mondello S, Hyon JY, Saleh W, et al
     Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39:795-803.
     PubMed     Abstract available
     
     
     
171. LORAND V, Nagy G, Balint Z, Komjati D, et al
     Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis.
     Clin Exp Rheumatol. 2021;39 Suppl 131:77-84.
     PubMed     Abstract available
     
     
     June 2021
172. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
     Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
     PubMed     Abstract available
     
     
     
173. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
     Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
     Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
     PubMed    
     
     
     
174. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
     Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
     Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
     PubMed    
     
     
     
175. PIARULLI A, Conversano C, Ciacchini R, Miniati M, et al
     Catastrophisation, chronic pain and sexuality: a cross-sectional investigation in fibromyalgia and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 10. pii: 17303.
     PubMed     Abstract available
     
     
     
176. SAITOU M, Noda K, Matsushita T, Ukichi T, et al
     Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
     Clin Exp Rheumatol. 2021 Jun 8. pii: 17108.
     PubMed     Abstract available
     
     
     
177. RAMIREZ J, Azuaga-Pinango AB, Frade-Sosa B, Gumucio-Sanguino R, et al
     Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Jun 8. pii: 16966.
     PubMed     Abstract available
     
     
     May 2021
178. WINTHROP KL, Tanaka Y, Lee EB, Wollenhaupt J, et al
     Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
     Clin Exp Rheumatol. 2021 May 28. pii: 16343.
     PubMed     Abstract available
     
     
     
179. BEHRENS F, Burmester GR, Feuchtenberger M, Kellner H, et al
     Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
     Clin Exp Rheumatol. 2021 May 14. pii: 16554.
     PubMed     Abstract available
     
     
     
180. THALMANN R, von Kempis J, Zgraggen A, Graf N, et al
     Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes.
     Clin Exp Rheumatol. 2021 May 5. pii: 16889.
     PubMed     Abstract available
     
     
     
181. TESTA D, Calvacchi S, Petrelli F, Giannini D, et al
     One year in review 2021: pathogenesis of rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39:445-452.
     PubMed     Abstract available
     
     
     
182. KONDO Y, Kaneko Y, Takei H, Tamai H, et al
     COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
     Clin Exp Rheumatol. 2021;39:631-638.
     PubMed     Abstract available
     
     
     
183. DITTO MC, Parisi S, Varisco V, Talotta R, et al
     Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
     Clin Exp Rheumatol. 2021;39:546-554.
     PubMed     Abstract available
     
     
     
184. IANNUCCELLI C, Lucchino B, Gioia C, Dolcini G, et al
     Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.
     Clin Exp Rheumatol. 2021;39 Suppl 130:153-160.
     PubMed     Abstract available
     
     
     
185. ALMIRALL M, Martinez-Mateu SH, Alegre C, Collado A, et al
     Dietary habits in patients with fibromyalgia: a cross-sectional study.
     Clin Exp Rheumatol. 2021;39 Suppl 130:170-173.
     PubMed     Abstract available
     
     
     April 2021
186. RETUERTO M, Trujillo E, Valero C, Fernandez-Espartero C, et al
     Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study.
     Clin Exp Rheumatol. 2021 Apr 27. pii: 17091.
     PubMed     Abstract available
     
     
     
187. AVOUAC J, Degrave R, Vergneault H, Combier A, et al
     Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
     Clin Exp Rheumatol. 2021 Apr 23. pii: 16697.
     PubMed     Abstract available
     
     
     
188. DI CARLO M, Tardella M, Filippucci E, Carotti M, et al
     Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease.
     Clin Exp Rheumatol. 2021 Apr 23. pii: 16655.
     PubMed     Abstract available
     
     
     March 2021
189. PERTSINIDOU E, Manivel VA, Westerlind H, Klareskog L, et al
     Rheumatoid arthritis autoantibodies and their association with age and sex.
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16843.
     PubMed     Abstract available
     
     
     
190. HASSELI R, Pfeil A, Hoyer BF, Krause A, et al
     Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16822.
     PubMed     Abstract available
     
     
     
191. PATLAN M, Paez A, Masso F, Amezcua-Guerra LM, et al
     Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis.
     Clin Exp Rheumatol. 2021 Mar 30. pii: 16892.
     PubMed    
     
     
     
192. ZHAO X, Gan Y, Jin Y, He J, et al
     Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome.
     Clin Exp Rheumatol. 2021;39:378-384.
     PubMed     Abstract available
     
     
     
193. CAMPOCHIARO C, Tomelleri A, Galli E, Cocchiara E, et al
     Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
     Clin Exp Rheumatol. 2021;39 Suppl 129:129-134.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: